UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
ProShares UltraPro Short Dow 30
SDOW
$183M
| $718K | ﹤0.01% |
14,164
+13,376
| +1,697% | +$658K |
|
5577
Timothy Plan High Dividend Stock ETF
TPHD
$367M
| $716K | ﹤0.01% |
19,701
+1,348
| +7% | +$51K |
|
|
ITOS
5578
DELISTED
iTeos Therapeutics
ITOS
| $715K | ﹤0.01% |
93,161
+49,396
| +113% | +$424K |
|
|
STKL
5579
DELISTED
SunOpta
STKL
| $714K | ﹤0.01% |
92,787
-6,941
| -7% | -$49.1K |
|
5580
Tiptree Inc
TIPT
$675M
| $714K | ﹤0.01% |
34,210
-202
| -0.6% | -$4.23K |
|
|
EFR
5581
Eaton Vance Senior Floating-Rate Fund
EFR
$317M
| $711K | ﹤0.01% |
55,564
-25,992
| -32% | -$334K |
|
|
GRX
5582
Gabelli Healthcare & Wellness Trust
GRX
$146M
| $711K | ﹤0.01% |
73,768
-7,636
| -9% | -$79.1K |
|
5583
Varex Imaging
VREX
$523M
| $711K | ﹤0.01% |
48,701
+26,912
| +124% | +$376K |
|
5584
ClearPoint Neuro
CLPT
$433M
| $710K | ﹤0.01% |
46,181
+15,213
| +49% | +$197K |
|
5585
Tactile Systems Technology
TCMD
$665M
| $710K | ﹤0.01% |
41,445
+32,808
| +380% | +$527K |
|
|
WRD
5586
WeRide Inc
WRD
$2.07B
| $710K | ﹤0.01% |
+50,067
| New | +$821K |
|
5587
Spok Holdings
SPOK
$241M
| $709K | ﹤0.01% |
44,164
+27,569
| +166% | +$437K |
|
5588
Amplify International Enhanced Dividend Income ETF
IDVO
$1.38B
| $707K | ﹤0.01% |
23,701
+4,723
| +25% | +$145K |
|
|
MSB
5589
Mesabi Trust
MSB
$306M
| $706K | ﹤0.01% |
25,113
+14,644
| +140% | +$380K |
|
5590
Standard BioTools
LAB
$314M
| $706K | ﹤0.01% |
403,153
+149,848
| +59% | +$279K |
|
|
TLN
5591
CALL
Talen Energy Corp
TLN
$16.7B
| $705K | ﹤0.01% |
+3,500
| New | +$683K |
|
5592
Nuveen Global High Income Fund
JGH
$356M
| $704K | ﹤0.01% |
54,845
+8,349
| +18% | +$109K |
|
5593
CALL
Castle Biosciences
CSTL
$979M
| $704K | ﹤0.01% |
26,400
| – | – |
|
|
ITIC
5594
Investors Title Co
ITIC
$547M
| $703K | ﹤0.01% |
2,971
+1,996
| +205% | +$500K |
|
5595
Nkarta
NKTX
$172M
| $701K | ﹤0.01% |
281,668
+188,302
| +202% | +$581K |
|
5596
PUT
Crocs
CROX
$6.55B
| $701K | ﹤0.01% |
6,400
-15,000
| -70% | -$1.75M |
|
5597
Cardlytics
CDLX
$21.5M
| $700K | ﹤0.01% |
18,877
+14,162
| +300% | +$542K |
|
5598
Invesco International BuyBack Achievers ETF
IPKW
$557M
| $700K | ﹤0.01% |
17,631
+14,994
| +569% | +$620K |
|
|
PLL
5599
PUT
DELISTED
Piedmont Lithium
PLL
| $699K | ﹤0.01% |
+80,000
| New | +$939K |
|
5600
American Outdoor Brands
AOUT
$157M
| $697K | ﹤0.01% |
45,766
+38,308
| +514% | +$413K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.